Neuropsychiatric symptoms, apolipoprotein e gene, and risk of progression to cognitive impairment, no dementia and dementia: The Aging, Demographics, and Memory Study (ADAMS)

International Journal of Geriatric Psychiatry

Volumn 28, Issue 7, 2013, Pages 672-680

  Beaudreau, Sherry A ^a,b   Kaci Fairchild, J ^a,b   Spira, Adam P ^c   Lazzeroni, Laura C ^a   O'Hara, Ruth ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

apolipoprotein 4; behavioral psychological symptoms in dementia; cognition; cognitive decline; cognitive disorders; Neuropsychiatric Inventory

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ARTICLE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; ETHNIC GROUP; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST;

AGE FACTORS; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84878746773     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3868     Document Type: Article

References (26)

1. ADAMS Supplement to the Health and Retirement Study, public use dataset. 2007. Produced and distributed by the University of Michigan with funding from the National Institute on Aging (grant number NIA U01AG009740). Ann Arbor, MI.
2. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association: Washington, D.C.
3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, D.C.
4. Bertram L, Lill CM, Tanzi RE,. 2010. The genetics of Alzheimer disease: back to the future. Neuron 68: 270-281.
5. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB,. 2012. Behavioral and psychological symptoms of dementia. Frontiers in Neurology 3: 73.
6. Cummings JL,. 1997. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 48: S10-S16.
7. Di Iulio F, Palmer K, Blundo C, et al,. 2010. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes. Int Psychogeriatr 22: 629-640.
8. D'Onofrio G, Panza F, Seripa D, et al,. 2011. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes. Int J Geriatr Psychiatry 26: 1062-1070.
9. Fernández-Martínez M, Castro J, Molano A, et al,. 2008. Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia. Curr Alzheimer Res 5: 61-69.
10. Geda YE, Knopman DS, Mrazek DA, et al,. 2006. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 63: 435-440.
11. Geda YE, Roberts RO, Knopman DS, et al,. 2008. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry 65: 1193-1198.
12. Heeringa SG, Fisher GG, Hurd M, et al,. 2009. Aging, Demographics and Memory Study (ADAMS): sample design, weighting and analysis for ADAMS. http://hrsonline.isr.umich.edu/sitedocs/userg/ADA MSSampleWeights-Jun2009.pdf
13. Jorge RE, Starkstein SE, Robinson, RG,. 2010. Apathy following stroke. Can J Psychiatry 55: 350-354.
14. Kim JM, Stewart R, Kim SY, et al,. 2011. Synergistic associations of depression and apolipoprotein E genotype with incidence of dementia. Int J Geriatr Psychiatry 26: 893-898.
15. Langa KM, Plassman BL, Wallace RB, et al,. 2005. The Aging, Demographics and Memory Study: study design and methods. Neuroepidemiology 25: 181-191.
16. Lyketsos CG, Lopez O, Jones B, et al,. 2002. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288: 1475-1483.
17. Lyketsos CG, Steinberg M, Tschanz JT, et al,. 2000. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 157: 708-714.
18. Muangpaisan W, Intalapaporn S, Assantachai P,. 2008. Neuropsychiatric symptoms in community-based patients with mild cognitive impairment and the influence of demographic factors. Int J Geriatr Psychiatry 23: 699-703.
19. Okura T, Plassman BL, Steffens DC, et al,. 2010. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc 58: 330-337.
20. Panza F, Frisardi V, Seripa D, D'Onofrio G, et al,. 2011. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Ageing Res Rev 11: 87-103.
21. Peters ME, Rosenberg PB, Steinberg M, et al,. 2012. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County study. Am J Geriatr Psychiatry 20: 416-424.
22. Plassman BL, Langa KM, Fisher GG, et al,. 2007. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29: 125-132.
23. Plassman BL, Langa KM, Fisher GG, et al,. 2008. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 18: 427-434. Erratum in Ann Intern Med Ann Intern Med. 2009 Aug 18;151(4):291-292.
24. Teng E, Lu PH, Cummings JL,. 2007. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord 24: 253-259.
25. Withall A, Broadaty H, Altendorf A, Sachdev PS,. 2011. A longitudinal study examining the independence of apathy and depression after stroke: the Sydney Stroke Study. Int Psychogeriatr 23: 264-273.
26. Xie SX, Ewbank DC, Chittams J, et al,. 2009. Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale. Alzhiemer Dis Assoc Disord 23: 268-74.